Recruiting
Phase 2

Neoadjuvant Chemoradiation for Resectable Glioblastoma

Sponsor:

Geisinger Clinic

Code:

NCT04209790

Conditions

Glioblastoma

Surgery

High Grade Glioma

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Neoadjuvant chemoradiation

Drug Therapy with Temozolomide (benzolamide) (Standard of Care)

Surgery post Radiation and Temozolomide (benzolamide)

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-31. This information was provided to ClinicalTrials.gov by Geisinger Clinic on 2024-04-29.